PYXS
PYXIS ONCOLOGY, INC.
🇺🇸 NYSE/NASDAQ
👑 Overview
📈 Performance
💵 Cost
🍃 Esg
🤓 Advanced
👨👩👧👦 Community
📈
-23.26%
Annual Growth
3 years average annual growth
🌏
7
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Pyxis Oncology, Inc. is a clinical-stage company focused on developing therapeutics to target difficult-to-treat cancers. The Company is building therapeutics that hold the potential for mono and combination therapies. Its clinical program portfolio includes PYX-201, PYX-106 and PYX-107. PYX-201, an antibody-drug conjugate (ADC) that targets Extradomain-B Fibronectin within the tumor stroma, and PYX-106, a fully human Siglec-15-targeting antibody designed to block suppression of T-cell proliferation and function, are being evaluated in ongoing Phase 1 clinical studies in multiple types of solid tumors. PYX-107 is a CD40 agonist antibody designed to maximize its agonistic properties. Its therapeutic candidates are designed to directly kill tumor cells and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion. Its ADC and immuno-oncology (IO) programs target a range of solid tumors resistant to current standards of care.
📈 Performance
Price History*
-71.56%
1M
1Y
All Time
Graph
Table
* US price history does not take into account stock splits
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$3.76
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in PYXS
7
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
40 weeks
💵 Average investment amount
$351
⏰ Last time a customer invested in PYXS
179 days
PYXS investor breakdown
💵 Income of investors
More than 200k
150k - 200k
13%
100k - 150k
38%
50k - 100k
38%
Less than 50k
13%
👶 Age of investors
18 - 25
26 - 34
29%
35 - 90
71%
🙋 Legal gender of investors
Female
71%
Male
29%
Pearlers who invest in PYXS also invest in...
🙌 Performance (5Yr p.a)
17.19%
📊 Share price
$524.95 USD
📈 HIGH PRICE GROWTH
🙌 Performance (5Yr p.a)
494.41%
📊 Share price
$135.40 USD
📈 HIGH PRICE GROWTH
Want more shares? Try these...
🙌 Performance (5Yr p.a)
-2.06%
📊 Share price
